High-performance pure blue thermally activated delayed fluorescence (TADF) emitters consisting of pyrimidine and diphenylacridan units are developed.
No takes yet. Share an insight, caveat, or question.
Park et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: